Your browser doesn't support javascript.
loading
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells.
Ward, Natasha C; Yu, Aixin; Moro, Alejandro; Ban, Yuguang; Chen, Xi; Hsiung, Sunnie; Keegan, James; Arbanas, Jaren M; Loubeau, Martine; Thankappan, Anil; Yamniuk, Aaron P; Davis, Jonathan H; Struthers, Mary; Malek, Thomas R.
Afiliación
  • Ward NC; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Yu A; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Moro A; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Ban Y; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Chen X; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Hsiung S; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Keegan J; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Arbanas JM; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136.
  • Loubeau M; Molecular Discovery Technologies, Bristol-Myers Squibb, Princeton, NJ 08543.
  • Thankappan A; Discovery Biology, Bristol-Myers Squibb, Princeton, NJ 08543.
  • Yamniuk AP; Discovery Biology, Bristol-Myers Squibb, Princeton, NJ 08543.
  • Davis JH; Molecular Discovery Technologies, Bristol-Myers Squibb, Princeton, NJ 08543.
  • Struthers M; Molecular Structure and Design, Bristol-Myers Squibb, Princeton, NJ 08543; and.
  • Malek TR; Discovery Biology, Bristol-Myers Squibb, Princeton, NJ 08543.
J Immunol ; 201(9): 2579-2592, 2018 11 01.
Article en En | MEDLINE | ID: mdl-30282751

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Interleucina-2 / Linfocitos T Reguladores / Diabetes Mellitus / Subunidad alfa del Receptor de Interleucina-2 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Interleucina-2 / Linfocitos T Reguladores / Diabetes Mellitus / Subunidad alfa del Receptor de Interleucina-2 / Tolerancia Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Año: 2018 Tipo del documento: Article